학술논문
A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
Document Type
Article
Author
Sklar, M.J.; Maiolatesi, S.; Patterson, N.; Sedegah, M.; Limbach, K.; Teneza-Mora, N.; Chuang, I.; Hollis-Perry, K.M.; Banania, J.G.; Guzman, I.; Ganeshan, H.; Reyes, S.; Hollingdale, M.R.; Wong, M.; Lindstrom, A.; Reyes, A.; Alcorta, Y.; Bankard, K.; Belmonte, A.; Belmonte, M.; Huang, J.; Gowda, K.; Inoue, S.; Velasco, R.; Hutter, J.; Lee, T.; Adams, N.; Tamminga, C.; Villasante, E.; Epstein, J.E.; Duplessis, C.A.; Garver, L.; Bergmann-Leitner, E.; Chaudhury, S.; Hunt, D.; Berrie, E.; Bellamy, D.; Bittaye, M.; Ewer, K.; Lawrie, A.; Hill, A.; Diggs, C.; Soisson, L.A.; Richie, T.L.
Source
In: PLoS ONE . (PLoS ONE, September 2021, 16 9 September)
Subject
Language
English
ISSN
19326203